RegSig is a regulatory signal intelligence platform.
Scored signals and portfolio assessment make each product’s exposure and recommended review actions explicit.
Portfolio intelligence
How signals map to products
Normalized product profiles from intake are assessed against the signal set; each product–signal pair yields exposure level and a structured action recommendation (type, owner, urgency) plus a short review narrative.
What decisions emerge
Where exposure is high or medium, which action types apply (e.g., claims, allergens, labeling), who should own the next step, and which products concentrate risk under a given signal or theme.
Operators
Run intake, confirm normalized products, execute portfolio assessment, and use dashboard and explorer views to prioritize signals and review lines.
Regulatory teams
Use signal records with origin and evidence to substantiate what changed, for whom, and on what horizon before committing review resources.
Portfolio managers
Compare concentration of exposure and high-urgency actions across products and signals to decide sequencing and ownership.
Request access if your organization needs structured regulatory signals tied to portfolio assessment and review-oriented outputs.
Requests are reviewed for fit and use case. Approved organizations receive onboarding steps for the platform environment. There is no implied instant self-serve trial unless separately confirmed.